STC2 and adrenal cortex carcinoma: It is found that high expression of STC2 can predict poor survival of adrenocortical carcinoma (ACC), CESC, ESCA, HNSC, KICH, KIRP, MESO, SARC, THYM and UVM (Figure 1C, Supplementary Figure 1-3).